CD24+ ovarian cancer cells have self-renewal, quiescence, and chemotherapy resistance properties and are enriched with stemness-related genes, e.g., Nestin, Bmi-1, and Oct4. This evidence concerns the gene POU5F1 and ovarian carcinoma.